Incyte Corporation
PROCESS OF PREPARING A PD-1/PD-L1 INHIBITOR

Last updated:

Abstract:

The present invention relates to processes of preparing PD-1/PD-L1 inhibitor (R)-1-((7-cyano-2-(3'-(3-(((R)-3-hydroxypyrrolidin-1-yl)methyl)- -1,7-naphthyridin-8-ylamino)-2,2'-dimethylbiphenyl-3-yl)benzo[d]oxazol-5-y- l)methyl)pyrrolidine-3-carboxylic acid, or salts thereof, related synthetic intermediates, and salts of the intermediates, where the PD-1/PD-L1 inhibitor is useful in the treatment of various diseases including infectious diseases and cancer.

Status:
Application
Type:

Utility

Filling date:

5 Nov 2021

Issue date:

12 May 2022